Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.3800
+0.0100
+(2.70%)
At close: April 1 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
112,492
96,940
84,578
81,208
64,600
Operating Income
-112,492
-96,940
-84,578
-81,208
-64,600
Net Non Operating Interest Income Expense
-4,100
-1,132
-3,571
-4,332
-1,924
Other Income Expense
-36,275
-12,704
76,184
59,063
--
Pretax Income
-152,867
-110,776
-11,965
-26,477
-66,524
Net Income Common Stockholders
-152,867
-110,776
-11,965
-26,477
-66,524
Diluted NI Available to Com Stockholders
-152,867
-110,776
-11,965
-26,477
-66,524
Total Operating Income as Reported
-112,492
-100,047
-84,578
-81,208
-64,600
Total Expenses
112,492
96,940
84,578
81,208
64,600
Net Income from Continuing & Discontinued Operation
-152,867
-110,776
-11,965
-26,477
-66,524
Normalized Income
-116,592
-98,072
-88,149
-85,540
-66,524
Interest Income
4,396
5,467
2,629
16
278
Interest Expense
8,496
6,599
6,200
4,348
2,202
Net Interest Income
-4,100
-1,132
-3,571
-4,332
-1,924
EBIT
-144,371
-104,177
-5,765
-22,129
-64,322
EBITDA
-137,156
-96,458
2,445
-13,888
-55,971
Reconciled Depreciation
7,215
7,719
8,210
8,241
8,351
Net Income from Continuing Operation Net Minority Interest
-152,867
-110,776
-11,965
-26,477
-66,524
Total Unusual Items Excluding Goodwill
-36,275
-12,704
76,184
59,063
--
Total Unusual Items
-36,275
-12,704
76,184
59,063
--
Normalized EBITDA
-100,881
-83,754
-73,739
-72,951
-55,971
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RCKTW Rocket Pharmaceuticals, Inc.
0.0467
-0.64%
IMTXW Immatics N.V.
0.0158
0.00%
COEPW Coeptis Therapeutics Holdings, Inc.
0.0080
-27.27%
ARGNF argenx SE
697.42
0.00%
LEXXW Lexaria Bioscience Corp.
0.3000
-7.69%
APLMW Apollomics, Inc.
0.0108
0.00%
SLNCF Silence Therapeutics plc
0.8450
-25.22%
IVBXF Innovent Biologics, Inc.
6.15
+4.24%
SLXNW Silexion Therapeutics Corp
0.0700
-0.14%
CNBX CNBX Pharmaceuticals Inc.
0.0100
+23.46%